Analysis BioVie Inc. (BIVI)
6/4/2024
Analysis of BioVie Inc. (BIVI)
BioVie Inc. (BIVI) has been showing some volatility in its stock price recently. The RSI indicator has been fluctuating around the 30-40 range, indicating a neutral to slightly bearish sentiment in the market.The MACD indicator has been hovering around the zero line, suggesting a lack of strong momentum in either direction. The MACD histogram has been fluctuating around zero, further confirming the lack of a clear trend.
In terms of moving averages, the stock price has been trading below the SMA, EMA, and WMA, indicating a bearish trend in the short term.
Overall, BioVie Inc. appears to be in a consolidation phase with no clear trend direction. Traders and investors may want to wait for a clearer signal before making any significant trading decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the transfer agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio, while the forward and trailing P/E ratios are moderate. The company's market capitalization and enterprise value are substantial, with a reasonable price-to-sales ratio.
The stock price summary includes beta, moving averages, and the range of prices over the past year. Dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics.
Overall, the data provides a comprehensive overview of the company's financial performance, stock statistics, valuation metrics, stock price movements, and dividends and splits information.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, reaching $97 billion in 2023 from $57.4 billion in 2020.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin, indicating strong operational performance.
8. Overall, the financial performance of the company in terms of revenue generation has been positive and shows a growth trend.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to support its operations over the years.
7. There is a need to monitor and manage current liabilities effectively to ensure financial stability.
8. Retained earnings have been positive in all years except for 2023, indicating profitability and reinvestment in the business.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant changes each year, with fluctuations in common dividends, stock repurchases, and debt issuances.
6. Investing activities also vary, with notable amounts spent on acquisitions, investments, and capital expenditures.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This represents an increase from the EPS of $1.17 reported a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This is higher than the EPS of $1.35 reported in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This shows growth compared to the EPS of $5.67 in the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, analysts project an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 expected for the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with the highest growth rate expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:- The company is expected to grow at a rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to grow at an average annual rate of 9.7%.
- However, in the past 5 years, the company has grown at a higher average annual rate of 20.1%.
Overall, it seems that the company is expected to maintain a steady growth rate in the upcoming periods, with a slightly higher growth rate projected for the next 5 years compared to the current year and next year.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end being $164, the high end being $275, and the average forecast at $204.58. The current price of the security is $192.25, which is below the median and average forecast, indicating that there is some optimism among analysts for the security to increase in value.
MACD of BIVI
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
